Li, Hongmei
Pei, Wenjie
Yang, Xiqun
Qu, Gengcuo
Hua, Qingchu
Liu, Lin
Wang, Yudi
Xu, Tingting
Chen, Yue http://orcid.org/0000-0003-4088-7649
Funding for this research was provided by:
Platform for innovation transformation in nuclear medicine (2021LZXNYD-P03)
Study on the creation and clinical transformation of probe targeting bone metastasis (2021LZXNYD-C02)
Development of Fluorine Multifunctional Module and Supporting 18F-FDG Kit (2021CXYZ02)
Integrated Diagnosis and Treatment of Colorectal Cancer with 68Ga/177Lu Labeled Fibroblast Activating Protein Inhibitors (21ZD005)
Research on 68Ga/177Lu integrated nuclear medicine with PSMA as the target for diagnosis and treatment (U20A20384)
Article History
Received: 13 December 2023
Accepted: 12 March 2024
First Online: 22 March 2024
Declarations
:
: This study was approved by the Institutional Review Board of the Affiliated Hospital of Southwest Medical University (KY2022114). All procedures involving human participants were performed in accordance with the ethical standards of the institutional committee, as well as the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any animal experiments. Informed consent was obtained from all participants included in the study.
: Informed consent was obtained from all participants included in the study.
: The authors declare that they have no competing interests.